CorVel Corp (CRVL) Stock Down 4.2% -- Now Undervalued? GF Score: 75/100
CorVel Corp (CRVL) shares dropped 4.2%, and despite this, the stock is considered undervalued with a GF Value™ estimate of $102.10 against its current price of $61.54. The company holds a GF Score™ of 75/100, indicating good long-term potential, primarily due to strong profitability. However, recent insider selling and low stock momentum suggest caution for potential investors.
CorVel Corporation (NASDAQ:CRVL) Q4 2026 Earnings Call Transcript
CorVel Corporation reported strong Q4 and fiscal year 2026 results, with revenues increasing by 7% to $249 million and $959 million respectively, and earnings per share growing significantly. Key drivers included double-digit growth in Network Solutions, strategic investments in AI and automation, and a shift towards proactive payment accuracy models with new large payer programs. The company also highlighted its robust financial position, including a debt-free balance sheet and active share repurchase program.
CorVel Q4 2026 Earnings Call Transcript
CorVel reported a 7% revenue growth for both Q4 and fiscal year 2026, reaching $249 million for the quarter and $959 million for the year. The company's EPS increased 17% to $2.14 for the fiscal year, driven by strong performance in Network Solutions, including significant new payer partnerships and increased bookings. CorVel emphasizes strategic investments in AI and automation to enhance efficiency and clinical insights, aiming for continued scalable growth and improved profitability.
CorVel reports FY 2026 results: annual revenue hits $959M
CorVel (NASDAQ:CRDL) announced strong financial results for fiscal year 2026, with annual revenue reaching $959 million, a 7% increase from the prior year. Net earnings per share grew by 17% to $2.14, driven by investments in AI and automation. The company also reported a liquid balance sheet with $233 million in cash and zero debt, and repurchased $20.1 million in common stock.
CorVel: Fiscal Q4 Earnings Snapshot
CorVel Corp. reported earnings of $31 million, or 61 cents per share, for its fiscal fourth quarter, with revenue reaching $248.5 million. For the full fiscal year, the health care management company achieved a profit of $110.3 million ($2.14 per share) and total revenue of $958.5 million. The financial data was compiled using information from Zacks Investment Research.
CorVel Corporation Reports 7% Revenue Growth and 17% EPS Increase for Fiscal Year 2026
CorVel Corporation announced strong financial results for fiscal year 2026, with a 7% increase in full-year revenue to $958.5 million and a 17% rise in diluted EPS to $2.14. The company reported robust cash reserves of $233 million with no debt and actively repurchased $20.1 million of its common stock. These positive outcomes were attributed to strategic investments in AI and automation, particularly within its CERIS Health and Workers’ Compensation divisions.
CorVel (CRVL) Q4 FY2026: EPS $0.61, Revenue $248.5M -- Still 42.
CorVel Corp (CRVL) reported strong financial results for Q4 and fiscal year 2026, with revenues reaching $248.5 million for the quarter and $958.5 million for the full year, and diluted EPS at $0.61 and $2.14, respectively. The company demonstrated significant year-over-year growth in both revenue and EPS, driven by its technology-enhanced healthcare and workers' compensation services. CorVel also strengthened its financial position with $233 million in cash and no borrowings, while repurchasing $20.1 million of common stock.
CorVel boosts EPS as healthcare payers adopt CERIS platform
CorVel (NASDAQ: CRVL) reported strong financial results for fiscal year 2026, with revenue increasing by 7% to $959 million and EPS rising by 17% to $2.14. The company's health division, CERIS, and P&C services drove this growth, supported by strategic investments in AI, automation, and telemedicine. CorVel ended the quarter with a healthy cash balance and repurchased $20.1 million in common stock, demonstrating financial strength and a commitment to shareholder returns.
CorVel Announces Revenues and Earnings
CorVel Corporation announced strong financial results for the quarter and fiscal year ended March 31, 2026. The company reported a 7% increase in fiscal year revenues to $959 million and a 17% increase in earnings per share to $2.14. Quarterly revenues rose 7% to $249 million, with earnings per share up 20% to $0.61, highlighting the successful adoption of its healthcare and risk management solutions.
CorVel Corp. Q4 Profit Climbs
CorVel Corp. (CRVL) announced an increase in its fourth-quarter profit, with earnings totaling $31.029 million, or $0.61 per share, up from $26.419 million, or $0.51 per share, in the prior year. The company's revenue also rose by 7.4% to $248.548 million for the period. These results show positive year-over-year growth in both income and sales for CorVel.
CorVel Announces Revenues and Earnings
CorVel Corporation announced strong financial results for the fiscal year ended March 31, 2026, with revenues increasing 7% to $959 million and earnings per share rising 17% to $2.14. The fourth quarter also showed significant growth in revenue and gross profit, with the company repurchasing $20.1 million of common stock. CERIS, CorVel's health division, is seeing strong demand for its prepayment platform, demonstrating the company's focus on innovative technology and integrated care models.
CorVel (NASDAQ: CRVL) grows FY 2026 revenue 7% with 17% EPS gain
CorVel Corporation reported strong financial growth for fiscal year 2026 and the quarter ended March 31, 2026. The company saw a 7% increase in fiscal year revenues to $958.5 million and a 17% gain in diluted earnings per share to $2.14. This performance was supported by strong demand in its CERIS health division and ongoing investments in technology and AI, alongside a healthy balance sheet with $233.1 million in cash and no borrowings.
CorVel Corp stock (US2210061099): claims management specialist in focus after latest quarterly resul
CorVel Corp, a US-based claims management specialist focusing on workers' compensation and managed care services, recently released its latest quarterly results, drawing attention from investors and analysts. The company's business model leverages proprietary technology to streamline claims processes, control costs, and improve return-to-work outcomes for insurers, employers, and government entities. Its performance is closely linked to US employment levels, healthcare costs, and the adoption of technology-enabled risk management solutions.
CorVel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges
CorVel Corp. has seen its stock valuation revised, with the current price at $58.52 after a significant decline over the past year, contrasting with the S&P 500's strong performance. Despite market challenges and a negative one-year return, the company demonstrates robust operational efficiency with a high return on capital employed and return on equity compared to its peers in the capital markets sector. The article highlights CorVel's key financial metrics such as its P/E ratio, price-to-book value, EV to EBIT, and EV to EBITDA, placing them in context with competitors like Ryan Specialty Holdings, Inc. and Goosehead Insurance, Inc.
CorVel Corp. Experiences Revision in Its Stock Evaluation Amid Market Volatility
CorVel Corp. has seen its stock valuation revised, with a P/E ratio of 45 and a price-to-book value of 12.60. The company has experienced significant stock volatility, with a 47.83% decline over the past year, contrasting sharply with the S&P 500's performance. Despite a robust valuation framework based on metrics like EV to EBIT and EV to EBITDA, CorVel's year-to-date return is down 15.05%, while its peers also present competitive and sometimes expensive valuations.
CorVel Corp stock (US2210061099): Recent price dip amid negative signals
CorVel Corp (CRVL) shares experienced a 0.85% decline on July 25, 2025, closing at $88.74, amid high volatility and insider selling, signaling caution for investors. The risk management firm, listed on Nasdaq, focuses on workers' compensation, auto, and liability claims, leveraging technology-driven platforms. While the company offers exposure to a resilient market, recent price weakness underscores short-term challenges, making upcoming earnings crucial for clarity.
CorVel Corporation to Host Live Earnings Release Webcast
CorVel Corporation (NASDAQ: CRVL) announced it will host a live webcast on Wednesday, May 20, 2026, at 11:30 AM ET to discuss its quarterly and fiscal earnings results. The webcast will cover financial performance, strategic initiatives, and the company's outlook, led by CEO Michael Combs and CFO Brian Nichols, and will include a Q&A session. Investors and analysts are invited to attend.
CorVel Corporation Announces Live Webcast for Upcoming Quarterly Earnings Discussion on May 20, 2026
CorVel Corporation will host a live webcast on May 20, 2026, at 11:30 AM Eastern Time to discuss its upcoming quarterly and fiscal earnings results, led by CEO Michael Combs and CFO Brian Nichols. The discussion will cover financial performance, strategic initiatives, and future outlook, including a Q&A session. The company, which uses AI and machine learning in its risk management solutions, also issued a safe harbor statement regarding forward-looking information.
CorVel Corporation to Host Live Earnings Release Webcast
CorVel Corporation announced it will host a live webcast on Wednesday, May 20, 2026, at 11:30 AM ET to discuss its upcoming quarterly and fiscal earnings results. The webcast will feature discussions on financial performance, strategic initiatives, and outlook by CEO Michael Combs and CFO Brian Nichols, and will include a Q&A session for investors, analysts, and interested parties.
CorVel Corporation to Host Live Earnings Release Webcast
CorVel Corporation (NASDAQ: CRVL) announced it will host a live webcast on Wednesday, May 20, 2026, at 11:30 AM Eastern Time to discuss its upcoming quarterly and fiscal earnings results. The event will feature presentations by Michael Combs, President and CEO, and Brian Nichols, CFO, covering financial performance, strategic initiatives, and outlook, followed by a Q&A session. Investors are encouraged to join the webcast to gain insights into CorVel’s performance and can submit questions in advance.
CorVel CEO to review earnings and outlook in May 20 webcast
CorVel Corporation (NASDAQ: CRVL) is set to host a live webcast on May 20, 2026, at 11:30 AM ET to discuss its upcoming quarterly and fiscal earnings results. President and CEO Michael Combs, along with CFO Brian Nichols, will provide insights into the company's financial performance, strategic initiatives, and future outlook, followed by a Q&A session. This webcast follows a mixed market reaction to previous earnings despite revenue growth, with recent focus on AI-powered solutions like CorVel Connected™.
CorVel Corporation to Host Live Earnings Release Webcast
CorVel Corporation announced it will host a live webcast on Wednesday, May 20, 2026, at 11:30 AM Eastern Time to discuss its upcoming quarterly and fiscal earnings results. The webcast will feature discussions on financial performance, strategic initiatives, and outlook led by CEO Michael Combs and CFO Brian Nichols, and will include a Q&A session for attendees. Investors and analysts are encouraged to join to gain insights into CorVel’s performance.
Vanguard Group Inc. Has $219.33 Million Position in CorVel Corp. $CRVL
Vanguard Group Inc. reduced its stake in CorVel Corp. by 1.4% in the fourth quarter, yet still holds a significant position of 3.24 million shares valued at $219.3 million. Despite substantial institutional ownership (51.36%), analysts have a cautious outlook, with Weiss Ratings downgrading the stock to "sell." CorVel, a technology-driven provider of workers' compensation solutions, has also seen recent insider selling.
CorVel (Nasdaq:CRVL) - Stock Analysis
CorVel Corporation (Nasdaq:CRVL) is trading at a 38.8% discount to its estimated fair value of US$95.59. The company recently launched "CorVel Connected," an AI-powered claims intelligence platform aimed at improving claims management efficiency. Despite strong earnings growth, insider selling has been notable, and the stock's price performance has lagged earnings growth over the last three years.
CorVel (CRVL) CFO exercises stock options, uses shares to pay taxes
CorVel Corp.'s CFO, Brian S. Nichols, exercised non-qualified stock options for 18 shares on May 1, 2026. He subsequently used 13 of these shares to cover the exercise price and associated tax obligations. This transaction resulted in a small net increase in his direct holdings of CorVel common stock.
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC®
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence solution embedded within its CareMC® claims management platform. This new offering aims to enhance end-to-end claim management by providing real-time, actionable insights and summarization of complex claim data to claims professionals, without replacing human judgment. The suite of AI-enabled capabilities includes claim summarization, natural-language Q&A, and intelligent claim assignment, designed to improve efficiency, consistency, and decision-making for both internal teams and clients.
CorVel Corporation Launches CorVel Connected, an AI-Powered Claims Intelligence Layer Embedded in CareMC
CorVel Corporation has announced the launch of CorVel Connected, an AI-powered claims intelligence layer integrated into its CareMC platform. This new solution uses artificial intelligence to streamline and enhance claims management, offering features like rapid medical record review and predictive insights. CorVel Connected aims to improve efficiency, accuracy, and communication for clients by providing actionable data and automating tasks.
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC®
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence layer integrated into its CareMC® claims management platform. This new technology aims to enhance claim processing efficiency by providing real-time, actionable insights and summarizations of complex data directly within workflows. It is designed to support human judgment rather than replace it, addressing the challenge of navigating vast amounts of claim-related information.
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC®
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence solution embedded within its CareMC® claims management platform. This new technology aims to enhance efficiency, consistency, and decision-making for claims professionals by synthesizing complex data, providing natural-language Q&A, and automating various claim processes. CorVel Connected seeks to empower human judgment rather than replace it, offering real-time insights for faster, more informed decisions and also provides enhanced client-facing dashboards for program performance analysis.
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence layer integrated into its CareMC® platform. This new solution aims to enhance claims management by embedding decision-support intelligence directly into workflows, helping claims professionals make faster and more informed decisions. CorVel Connected includes AI-powered summarization, natural language Q&A, and real-time medical document summaries, designed to improve efficiency and consistency while preserving human judgment in complex claims.
CorVel puts AI claim summaries and Q&A into adjusters' daily workflow
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence layer integrated into its CareMC® claims management platform. This new suite of tools aims to enhance the efficiency of claims professionals by providing real-time decision support, AI claim summarization, and natural-language Q&A, among other features. The company emphasizes that CorVel Connected is designed to augment human judgment rather than replace it, helping adjusters navigate complex claim data more effectively.
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC®
CorVel Corporation has launched CorVel Connected™, an AI-powered claims intelligence layer integrated into its CareMC® claims management platform. This new technology aims to enhance claim management efficiency by embedding decision-support intelligence directly into daily workflows, helping professionals make faster, more informed decisions by organizing, prioritizing, and summarizing relevant data. CorVel Connected includes features like AI-powered summarization, natural-language Q&A, and intelligent claim assignment, all designed to augment human judgment rather than replace it.
M&T Bank Corp Increases Stock Holdings in CorVel Corp. $CRVL
M&T Bank Corp significantly increased its stake in CorVel Corp. by 1,230% in Q4 2025, acquiring 58,669 additional shares and bringing its total holdings to 63,439 shares worth approximately $4.29 million. This investment now represents about 0.12% of CorVel. Despite this, CorVel recently received a "Sell" rating downgrade from Weiss Ratings, and analysts generally hold a "Sell" consensus for the stock.
CorVel (NASDAQ: CRVL) EVP exercises 1,050 options, delivers 830 shares for taxes
CorVel Corp's EVP, Mark E. Bertels, exercised 1,050 non-qualified stock options at $39.827 per share on April 22, 2026. To cover the exercise price and tax liabilities, 830 shares were delivered back to the company in two transactions at prices of $57.40 and $56.76 per share. This is a routine equity compensation event, not a discretionary open-market sale, and reflects standard handling of stock options.
Boston Trust Walden Corp Has $33.44 Million Stock Position in CorVel Corp. $CRVL
Boston Trust Walden Corp. significantly reduced its stake in CorVel Corp. (NASDAQ:CRVL) by 6.6% in the fourth quarter, now holding 494,152 shares valued at approximately $33.44 million. This move coincides with an insider, Maxim Shishin, selling 2,400 shares and a downgrade of CorVel's rating from "hold" to "sell" by Weiss Ratings, aligning with a consensus "Sell" rating from analysts. The company currently has a market capitalization of $2.94 billion and last reported earnings of $0.47 per share with revenues of $235.63 million.
CorVel Corp stock (US2210061099): Is its workers' comp edge strong enough for new upside?
CorVel Corp specializes in risk management solutions for healthcare claims, particularly in workers' compensation, offering technology-enabled tools to control costs for employers and insurers. The company's asset-light model, strategic investments in AI, and focus on operational efficiencies position it well in the fragmented U.S. workers' comp market. While facing risks like client concentration and regulatory changes, analysts view CorVel positively for its niche dominance and potential for consistent returns.
CorVel Corp stock (US2210061099): Is its workers' comp edge strong enough for new upside?
CorVel Corp specializes in risk management solutions for healthcare claims, particularly in workers' compensation, offering technology-enabled services to control costs for employers and insurers. The company's asset-light model, strategic use of AI and data analytics, and focus on outcome-based solutions position it strongly in a fragmented market. While analyst views are positive, risks include client concentration and regulatory changes, requiring investors to monitor key metrics for sustained growth.
CorVel (NASDAQ:CRVL) Share Price Passes Below 200-Day Moving Average - Here's What Happened
CorVel's stock price fell below its 200-day moving average of $64.53, trading as low as $54.71 and closing at $55.96 with a volume of 161,331 shares. This decline follows a "sell" rating downgrade from Weiss Ratings and an insider selling 2,400 shares, representing a 25.4% reduction in their holding. Despite this, insiders collectively own 44.56% of the company, and various institutional investors have recently increased their stakes.
CORVEL (CRVL) VP of Accounting acquires 50 ESPP shares in Form 4 filing
CORVEL's Vice President of Accounting, Jennifer Yoss, acquired 50 shares of common stock through an Employee Stock Purchase Plan at a price of $51.9175 per share. This transaction, exempt under SEC Rule 16b-3(c), increased her direct holdings to 2,173 shares. The filing is categorized as neutral in impact and sentiment, reflecting a routine, compensation-related acquisition.
CorVel (NASDAQ:CRVL) Share Price Crosses Below 200-Day Moving Average - What's Next?
CorVel (NASDAQ:CRVL) stock price recently fell below its 200-day moving average, trading at $54.22 with a 200-day moving average of $66.65. This technical sell signal comes despite Weiss Ratings reissuing a "Hold" rating, and the company reporting a $2.77 billion market cap, a P/E of 26.58, last-quarter EPS of $0.47 on $235.63 million revenue, with a 30.15% ROE and 11.23% net margin. Insider Maxim Shishin sold 2,400 shares, reducing his position, while institutional investors like Royal Bank of Canada, AQR Capital, and Millennium Management increased their stakes.
CRVL SEC Filings - Corvel Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Corvel Corp (CRVL) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It details how these documents offer insight into the company's governance, financial reporting, and significant events like AI-driven platform enhancements or stock splits. The article also provides recent filing summaries, including insider transactions and proxy statements for the upcoming annual meeting.
Vanguard disaggregates holdings after realignment; CorVel (CRVL) shows 0% reported
The Vanguard Group has amended its Schedule 13G for CorVel Corp (CRVL) to report 0% ownership, following an internal realignment. This change is administrative, as certain Vanguard subsidiaries will now report their beneficial ownership separately in accordance with SEC Release No. 34-39538. Investors should anticipate separate filings from Vanguard affiliates for CorVel in the future.
CorVel Executive's Stock Sale Raises Eyebrows Amid Declining Shares
CorVel's CIO, Shishin Maxim, sold 2,400 shares for $130,000 on March 16, 2026, leading to a 25.40% reduction in his direct holdings, at a time when the company's shares had fallen by 50% over the past year. Despite the stock decline, CorVel reported strong financial performance with $236 million in revenue for the last quarter and a robust balance sheet. The sale is viewed by some as routine liquidity management, but its timing, coupled with falling share prices, has drawn attention.
CorVel Corp stock faces quiet trading amid steady healthcare services demand and remote work hiring
CorVel Corp (US2210061099), a leader in workers' compensation and healthcare management solutions, is experiencing quiet trading despite steady demand for its services and a continued push for remote hiring. The company's resilience is highlighted by recent job postings for remote claims specialists and billing roles, signifying sustained business needs in a post-pandemic economy. For US investors, CorVel offers a defensive play in healthcare services due to its low debt, consistent cash flows, and focus on specialized risk management.
Argent Capital Management LLC Takes $1.80 Million Position in CorVel Corp. $CRVL
Argent Capital Management LLC has acquired a new position in CorVel Corp. (NASDAQ:CRVL) during the fourth quarter, purchasing 26,601 shares valued at approximately $1.8 million, representing 0.05% of the company. Other institutional investors also adjusted their stakes. Concurrently, an insider sold 2,400 shares, decreasing their holding by 25.4%, while analysts like Weiss Ratings reiterated a "Hold" rating on the stock.
Corvel CEO Combs sells $432k in shares
Corvel CEO Michael G. Combs sold 8,013 shares of common stock for $432,702 on March 9, 2026, reducing his direct ownership to 40,760 shares. Despite the sale and a 49% drop in stock price over the past year, CorVel (NASDAQ:CRVL) is considered undervalued by InvestingPro, with management actively buying back shares. The company recently reported stable third-quarter 2026 earnings, though its stock decline suggests investor apprehension about future growth prospects.
Corvel (CRVL) CIO Shishin sells $129,603 in stock By Investing.com
Corvel (CRVL) Chief Information Officer Maxim Shishin sold 2,400 shares of common stock for approximately $129,603 on March 16, 2026. On the same day, Shishin also exercised options to acquire 2,400 shares for $95,584. Despite the stock being down 49% over the past year, InvestingPro data suggests the company is undervalued, though it trades at a high P/E ratio relative to near-term earnings growth.
Corvel (CRVL) CIO Shishin sells $129,603 in stock
Maxim Shishin, CIO of Corvel Corp (CRVL), sold 2,400 shares totaling $129,603 on March 16, 2026, after exercising options for the same number of shares. This transaction occurred as the stock has declined 49% over the past year but is considered undervalued based on Fair Value analysis. The company recently reported stable Q3 2026 earnings, though its stock saw a significant premarket drop, indicating investor concerns.
CorVel (NASDAQ:CRVL) Insider Sells $129,600.00 in Stock
CorVel (NASDAQ:CRVL) insider Maxim Shishin sold 2,400 shares of the company's stock on March 16th for $129,600, reducing his position by 25.4%. Following the sale, Shishin directly owns 7,050 shares valued at approximately $380,700. The company's stock traded up 0.4% to $53.96, with a market capitalization of $2.76 billion.
CorVel (CRVL) CIO exercises options, sells 2,400 newly acquired shares
CorVel Corp's Chief Information Officer, Maxim Shishin, exercised 2,400 non-qualified stock options at $39.827 per share and subsequently sold all 2,400 newly acquired common shares in an open-market transaction for $54.0016 per share. Following these transactions, Shishin directly owns 7,050 CorVel common shares. This transaction fully eliminated the specific option grant.
